Approximately 3 million FreeStyle Libre 3 and FreeStyle Libre 3 Plus sensors need to be replaced due to a risk of incorrect glucose readings. Abbott has received reports of 736 severe adverse events and seven deaths that may be related to this issue.
The timing of this new guidance from the Heart Rhythm Society and American College of Cardiology could not have been better—the document went live just as CMS finalized its decision to cover cardiac ablation procedures performed in ASCs.
Gregg Stone, MD, spoke to Cardiovascular Business about early data from the ATHENS-HF trial. Ten heart failure patients were treated with the adjustable device, and each implant was a success.
The largest healthcare system in the Middle East is partnering with Nvidia to decode the human genome. If successful, the AI-heavy project will translate almost the entire language of heredity into actionable information.
There have been reports of the retrievable device being difficult to use in a way that increases the risk of patients injuries. Customers are urged to stop using these devices right away.
Advanced Imaging Specialists, Danbury, Connecticut, alleges the breach of contract occurred shortly after it started performing services for 3 New England hospitals.
U.S. Reps. Kathy Castor, D-Fla., Brian Fitzpatrick, R-Pa., and Debbie Wasserman Schultz, D-Fla., recently reintroduced the Increasing Access to Lung Cancer Screening Act.
Children's Wisconsin admitted that it accidentally threw out the brain of a 24-year-old woman who survived a rare childhood illness as a result of a novel gene therapy. A researcher called the organ “irreplaceable.”
A model of i-View Video Laryngoscopes manufactured by Intersurgical is defective and will need to be removed from patient care settings and supply houses immediately, as they pose a serious risk to patient health.
The deal will not be finalized until approved by Exact Sciences’ shareholders. With it, Abbott gains control of new diagnostic tools, including a popular at-home test for colorectal cancer.
Approximately 3 million FreeStyle Libre 3 and FreeStyle Libre 3 Plus sensors need to be replaced due to a risk of incorrect glucose readings. Abbott has received reports of 736 severe adverse events and seven deaths that may be related to this issue.
The timing of this new guidance from the Heart Rhythm Society and American College of Cardiology could not have been better—the document went live just as CMS finalized its decision to cover cardiac ablation procedures performed in ASCs.
Gregg Stone, MD, spoke to Cardiovascular Business about early data from the ATHENS-HF trial. Ten heart failure patients were treated with the adjustable device, and each implant was a success.
